Generated by GPT-5-mini| Genetic and Rare Diseases Information Center | |
|---|---|
| Name | Genetic and Rare Diseases Information Center |
| Formation | 2002 |
| Headquarters | United States |
| Parent organization | National Institutes of Health |
Genetic and Rare Diseases Information Center The Genetic and Rare Diseases Information Center provides centralized information and support for individuals, families, clinicians, and researchers affected by rare and genetic conditions. It operates within the ecosystem of biomedical National Institutes of Health programs and interfaces with patient advocacy organizations, academic medical centers, and federal agencies. The center serves as a bridge among stakeholders such as clinical researchers at Mayo Clinic, patient groups like Global Genes, regulatory bodies like the Food and Drug Administration, and funding institutions including the National Science Foundation.
The center offers curated content on thousands of rare and genetic disorders, drawing on clinical guidance from institutions such as Johns Hopkins Hospital, Cleveland Clinic, Massachusetts General Hospital, and academic departments at Harvard Medical School, Stanford University School of Medicine, and the University of California, San Francisco. It synthesizes authoritative sources from government entities like the Centers for Disease Control and Prevention, the Office of Rare Diseases Research, and the National Center for Advancing Translational Sciences, while coordinating with nonprofit consortia including Orphanet and foundations such as the Ewing Marion Kauffman Foundation. The center's outputs are used by specialists affiliated with organizations like the American College of Medical Genetics and Genomics and by patient advocates from groups such as the Cystic Fibrosis Foundation and the Muscular Dystrophy Association.
Services include condition summaries, genetics explanations, diagnostic guidance, and links to clinical trials listed by ClinicalTrials.gov and academic trial sites at University of Pennsylvania Health System and Dana–Farber Cancer Institute. The resource connects callers to support organizations like the March of Dimes and the American Red Cross for emergency referral contexts, and provides literature pointers to journals such as The New England Journal of Medicine, Nature Genetics, The Lancet, and Genetics in Medicine. It assists users in navigating social supports through partnerships with entities like Social Security Administration programs and patient registry initiatives at Johns Hopkins Bloomberg School of Public Health and the Broad Institute.
The center is administered within the framework of the National Human Genome Research Institute and coordinates policy and compliance with ethics offices across institutions such as the Office for Human Research Protections and the HHS Office of the Inspector General. Governance involves collaboration with advisory boards populated by clinicians from hospitals like Children's Hospital of Philadelphia, researchers from Cold Spring Harbor Laboratory, representatives from patient organizations like Amyotrophic Lateral Sclerosis Association, and liaisons from federal partners including the Agency for Healthcare Research and Quality. Financial and programmatic oversight aligns with federal appropriations processes involving committees of the United States Congress and grant mechanisms administered by agencies such as the National Cancer Institute.
The center supports translational research networks comprising investigators at UCLA Medical Center, Mount Sinai Health System, Vanderbilt University Medical Center, and international collaborators at institutions like Karolinska Institutet and University College London. Educational initiatives include continuing medical education collaborations with the American Medical Association and resource development with professional societies such as the European Society of Human Genetics and the American Society of Human Genetics. Outreach engages patient communities through partnerships with advocacy groups including Rare Disease UK, EveryLife Foundation for Rare Diseases, and international consortia like the International Rare Diseases Research Consortium. The center disseminates findings at conferences such as the American Association for the Advancement of Science annual meeting, the European Society for Paediatric Research congress, and symposia hosted by Cold Spring Harbor Laboratory.
Information is accessible via telephone, email, and digital portals interoperable with clinical resources at Epic Systems Corporation and research platforms at the National Center for Biotechnology Information. Materials are developed to align with standards used by the World Health Organization and reporting frameworks such as the International Classification of Diseases. The center facilitates referrals to clinical genetics services at facilities like Seattle Children's Hospital and pediatric research programs at St. Jude Children's Research Hospital, and supports investigators applying for funding to agencies like the Wellcome Trust and the Bill & Melinda Gates Foundation.
Since its establishment, the center has contributed to improved diagnostic pathways and family support systems by working with genomics initiatives such as the Human Genome Project, the All of Us Research Program, and large-scale sequencing efforts at centers including the Broad Institute and Sanger Institute. Impact is evident in collaborations with registries and trials that led to approvals by the Food and Drug Administration and policy recommendations from advisory bodies like the Advisory Committee on Heritable Disorders in Newborns and Children. The center's role in public health messaging has intersected with campaigns run by organizations such as United Nations Children's Fund and World Health Organization emergency communications during rare disease awareness events.
Category:Health information